Login / Signup

The cost-effectiveness of progesterone in preventing miscarriages in women with early pregnancy bleeding: an economic evaluation based on the PRISM trial.

C B Okeke OgwuluI GoranitisA J DevallVersha CheedI D GallosL J MiddletonH M HarbH M WilliamsA EapenJ P DanielsA AhmedR Bender-AtikK BhatiaC BottomleyJ BrewinM ChoudharyS DebW C DuncanA K EwerK HinshawT HollandF IzzatJ JohnsM LumsdenP MandaJ E NormanN NunesC E OvertonK KriedtS QuenbyS RaoJ RossA ShahidM UnderwoodN VaithilinghamL WatkinsC WykesA W HorneD JurkovicA CoomarasamyT E Roberts
Published in: BJOG : an international journal of obstetrics and gynaecology (2020)
Progesterone treatment is likely to be cost-effective in women with early pregnancy bleeding and a history of miscarriage.
Keyphrases
  • atrial fibrillation
  • estrogen receptor
  • clinical trial
  • phase iii
  • phase ii
  • randomized controlled trial
  • replacement therapy